Pilot Study to Test Nitric Oxide Gas Treatment on Nontuberculous Mycobacteria Infections
News
A small, pilot Phase 1/2 clinical trial evaluating the safety and efficacy of Thiolanox inhaled nitric oxide gas in treating nontuberculous mycobacteria (NTM) infection has been approved by Health Canada. ... Read more